BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17003742)

  • 1. [Endometrial hyperplasia: A review].
    Brun JL; Descat E; Boubli B; Dallay D
    J Gynecol Obstet Biol Reprod (Paris); 2006 Oct; 35(6):542-50. PubMed ID: 17003742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Endometrial hyperplasias resistant to progestins: alternatives to traditional treatments].
    Brun JL; Belaisch J; Rivel J; Hocké C
    Gynecol Obstet Fertil; 2002 Mar; 30(3):244-51. PubMed ID: 11998214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chinese guidelines on the management of endometrial hyperplasia.
    Li L; Zhu L;
    Eur J Surg Oncol; 2024 Jul; 50(7):108391. PubMed ID: 38735237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and management of abnormal uterine bleeding in premenopausal women.
    Sweet MG; Schmidt-Dalton TA; Weiss PM; Madsen KP
    Am Fam Physician; 2012 Jan; 85(1):35-43. PubMed ID: 22230306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methods and efficacy of medical and surgical treatment of non functional menorrhagia].
    Brun JL; André G; Descat E; Creux H; Vigier J; Dallay D
    J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S368-83. PubMed ID: 19268216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasonographic evaluation of the endometrium in postmenopausal vaginal bleeding.
    Davidson KG; Dubinsky TJ
    Radiol Clin North Am; 2003 Jul; 41(4):769-80. PubMed ID: 12899491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triage of abnormal postmenopausal bleeding: a comparison of endometrial biopsy and transvaginal sonohysterography versus fractional curettage with hysteroscopy.
    O'Connell LP; Fries MH; Zeringue E; Brehm W
    Am J Obstet Gynecol; 1998 May; 178(5):956-61. PubMed ID: 9609566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levonorgestrel intra-uterine system as a treatment option for complex endometrial hyperplasia.
    Haoula ZJ; Walker KF; Powell MC
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):176-9. PubMed ID: 21741152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current treatment of dysfunctional uterine bleeding.
    Bongers MY; Mol BW; Brölmann HA
    Maturitas; 2004 Mar; 47(3):159-74. PubMed ID: 15036486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levonorgestrel-releasing intrauterine device versus dydrogesterone for management of endometrial hyperplasia without atypia.
    El Behery MM; Saleh HS; Ibrahiem MA; Kamal EM; Kassem GA; Mohamed Mel S
    Reprod Sci; 2015 Mar; 22(3):329-34. PubMed ID: 25001020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hysteroscopic view in atypical endometrial hyperplasias: A correlation with pathologic findings on hysterectomy specimens.
    Garuti G; Mirra M; Luerti M
    J Minim Invasive Gynecol; 2006; 13(4):325-30. PubMed ID: 16825075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review.
    Buttini MJ; Jordan SJ; Webb PM
    Aust N Z J Obstet Gynaecol; 2009 Jun; 49(3):316-22. PubMed ID: 19566568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of postmenopausal bleeding to prevent endometrial cancer.
    Gambrell RD; Castaneda TA; Ricci CA
    Maturitas; 1978 Sep; 1(2):99-106. PubMed ID: 755962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial ablation for postmenopausal uterine bleeding induced by hormone replacement therapy.
    Phillips DR
    J Am Assoc Gynecol Laparosc; 1995 Aug; 2(4):389-93. PubMed ID: 9050590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin-Releasing Hormone Agonist Combined With a Levonorgestrel-Releasing Intrauterine System or Letrozole for Fertility-Preserving Treatment of Endometrial Carcinoma and Complex Atypical Hyperplasia in Young Women.
    Zhou H; Cao D; Yang J; Shen K; Lang J
    Int J Gynecol Cancer; 2017 Jul; 27(6):1178-1182. PubMed ID: 28562472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of diagnostic accuracy between endometrial curettage and pipelle aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group Study (KGOG 2019).
    Kim MK; Seong SJ; Lee TS; Ki KD; Lim MC; Kim YH; Kim K; Joo WD
    Jpn J Clin Oncol; 2015 Oct; 45(10):980-2. PubMed ID: 26206899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resectoscopic surgery in women with abnormal uterine bleeding and nonatypical endometrial hyperplasia.
    Vilos GA; Harding PG; Ettler HC
    J Am Assoc Gynecol Laparosc; 2002 May; 9(2):131-7. PubMed ID: 11960036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
    Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
    Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Wheeler DT; Bristow RE; Kurman RJ
    Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal inhibition of the endometrium for resectoscopic endometrial ablation.
    Brooks PG; Serden SP; Davos I
    Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1601-6; discussion 1606-8. PubMed ID: 1904683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.